RP Management, LLC - Q3 2016 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2016
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOHAVEN PHARMACTL HLDG CO L16Q3 202277.6%
VIRACTA THERAPEUTICS INC14Q2 20245.7%
EPIZYME INC11Q2 202244.1%
BIOCRYST PHARMACEUTICALS INC11Q2 202452.0%
EPIZYME INC11Q2 202213.9%
CYTOKINETICS, INC11Q2 202429.7%
SUNESIS PHARMACEUTICALS INC9Q4 20200.1%
IMMUNOMEDICS INC8Q3 202055.7%
BIOHAVEN LTD7Q2 202489.2%

View RP Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
RP Management, LLC Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CYPRESS BIOSCIENCE INCDecember 23, 20103,815,0009.9%

View RP Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-13
13F-HR2024-05-08
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
42022-08-16

View RP Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export RP Management, LLC's holdings

CSVXLS